10/06/2026
Telehealth grew 38x during the pandemic.
It never came back down.
Decentralized clinical trials went from a niche methodology to the dominant model in under five years. The at-home diagnostics market is projected to hit $8 billion by 2027.
The direction is clear.
Healthcare is moving into the home. Into the community. Away from centralized facilities that were designed for a different era of medicine.
But infrastructure hasn't kept pace.
The virtual visit works. The at-home prescription delivery works. The remote monitoring device works.
Getting a blood draw has still required someone to get in a car.
We think that's the last major friction point in the at-home healthcare experience — and we're building the infrastructure to remove it.
Mobile, certified specimen collection. API-connected. Nationwide. Built for the way healthcare is actually being delivered now, not ten years ago.
The companies building the at-home health stack are doing it right now.
The ones who get the infrastructure right — specimen collection included — are going to define what the patient experience looks like for the next decade.
We're building that infrastructure.
We'd love to build it with you.